JPRN-UMIN000016123招募中未知
Effect of an N/L-type Ca channel blocker on prorenin and soluble (pro)renin receptor levels in hypertensive patients: A randomized controlled trial - Effect of an N/L-type Ca channel blocker on prorenin and soluble (pro)renin receptor levels in hypertensive patients: A randomized controlled trial
Tokyo Women's Medical University0 个研究点目标入组 100 人开始时间: 2015年1月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1,Patients with chronic kidney disease (CKD) stage 4 or greater 2,Patients with past histories of myocardial or cerebral infarction within the previous six months 3,Expectant mothers and lactating women 4,Patiens who have allergy to amlodipine or cilnidipine
研究者
相似试验
招募中
不适用
The effect of L/N type Calcium channel blocker on blood pressure variability in elderly hypertensive patientsHypertensionJPRN-UMIN000014843Osaka university graduate school of medicine The department of geriatric medicine and nephrology40
招募中
不适用
Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysisendstage chronic kidney diseaseJPRN-UMIN000023201Department of Nephrology and Dialysis, Moriguchi Keijinnkai Hospital20
已完成
不适用
Effect of T/L-type calcium channel blockers on serum biomarkers for cardiovascular functioHypertensionJPRN-UMIN000008325Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine60
招募中
不适用
Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease.JPRN-UMIN000005523Ajinomoto Pharmaceuticals Co., LTD.3,000
招募中
不适用
Evaluation of L/N type Ca2+ channel blocker (cilnidipine) in hypertension complicated diabetes or sleep apnea syndrome ; Trial for the effects of improvementof arteriosclerosis and renal function.Diabetes/Hypertension/Sleep apnea syndromeJPRN-UMIN000014635Kanazawa Medical Clinic50